# The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer

> **NCT02004327** · PHASE1 · COMPLETED · sponsor: **Dong Wha Pharmaceutical Co. Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Diabetic Kidney Disease

## Interventions

- **DRUG:** DW1029M300mg
- **DRUG:** DW1029M600mg
- **DRUG:** DW1029M1200mg

## Key facts

- **NCT ID:** NCT02004327
- **Lead sponsor:** Dong Wha Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2015-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02004327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02004327, "The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02004327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*